Skip to main content

Table 1 Patient and treatment characteristics

From: Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma

Characteristic

n (%) or median (range)

Sex

 Male

46 (82.14%)

 Female

10 (17.86%)

Age (years)

61 (34–84)

Karnofsky performance status (10%)

  ≤ 80

34 (60.71%)

  > 90

22 (39.29%)

Hepatitis B virus

 Positive

49 (87.5%)

 Negative

7 (12.5%)

Stagea

 II

13 (23.21%)

 III

25 (44.64%)

 IV

18 (32.14%)

Treatment strategy

 RT alone

9 (16.07%)

 RT combined with TACE

47 (83.93%)

Prescription dose for liver tumor (cGy)

5400 (4500–6200)

Live tumor(cm3)

151.81 (4.20–976.93)

Plan target volume for liver tumor(cm3)

342.29 (19.20–1442.27)

  1. V 5 volumetric proportion of spleen receiving ≥ 5 Gy
  2. aAmerican Joint Committee on Cancer staging manual, seventh edition. Frequency (percent proportions) are shown for all categorical variables and Medians (range) are shown for all continuous variables